History | Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 127 KB)

Published:

17 November 2021
Register of interests (PDF 279 KB)

Published:

19 November 2021

Final draft guidance

Final draft guidance
Final appraisal document (PDF 212 KB)

Published:

15 October 2021
Committee papers (PDF 8.83 MB)

Published:

15 October 2021
Public committee slides (PDF 825 KB)

Published:

15 October 2021

Invitation to participate

Final scope (PDF 180 KB)

Published:

08 January 2021
Draft scope and provisional stakeholder list comments table (post-referral) (PDF 219 KB)

Published:

08 January 2021
Equality impact assessment (Scoping) (PDF 120 KB)

Published:

08 January 2021
Final stakeholder list (PDF 153 KB)

Published:

08 January 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 194 KB)

Published:

01 October 2020
Draft matrix post referral (PDF 154 KB)

Published:

01 October 2020